Schedule an Appointment (424) 248-3134 Contact Us

What’s Next in Clinical TMS Study for PTSD, MDD

By Jennifer DiSanto | January 23, 2018

Read Full Story Here

In a recently-published commentary, researchers discussed the growing interest in transcranial magnetic stimulation (TMS) therapy for post-traumatic stress disorder (PTSD) and major depressive disorder (MDD), and what it brings in patient symptoms.

TMS, which was approved by the US Food and Drugs Administration (FDA) for drug-resistant depression in 2009, has recently experienced a growth in clinical use, Mira Hammoud, MD, and Mohammed Milad, PhD, from the Department of Psychiatry, University of Illinois at Chicago, noted in their commentary.

Although previous studies have supported the use of TMS for treatment of PTSD, they haven’t clarified the mechanisms it uses to affect and improve symptoms. Use of TMS to treat MDD has a larger collection of literature that, according to the commentary, supports the idea that “TMS modulates functional connectivity in several brain regions implicated in the pathophysiology of MDD, including the subgenual anterior cingulate cortex (sgACC) and its connections with the default mode network (DMN).”

Read Full Story Here

Do you have more questions about tinnitus?